Literature DB >> 21998480

Time to refocus on HSV interventions for HIV prevention?

Clare Tanton, Laith J Abu-Raddad, Helen A Weiss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21998480      PMCID: PMC3209813          DOI: 10.1093/infdis/jir653

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  33 in total

1.  No selection of nucleoside reverse transcriptase inhibitor resistance associated mutations by acyclovir suppressive therapy in herpes simplex virus-2/HIV-1 dually infected persons.

Authors:  Jerome LeGoff; Clare Tanton; Constance Delaugerre; Helen A Weiss; John Changalucha; David A Ross; Kokugonza Mugeye; Laurent Belec; Richard J Hayes; Deborah Watson-Jones
Journal:  AIDS       Date:  2010-10-23       Impact factor: 4.177

2.  Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.

Authors:  Deborah Watson-Jones; Anna Wald; Connie Celum; Jairam Lingappa; Helen A Weiss; John Changalucha; Kathy Baisley; Clare Tanton; Richard J Hayes; Joshua O Marshak; Rula Green Gladden; David M Koelle
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

3.  Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

Authors:  C Celum; A Wald; J R Lingappa; A S Magaret; R S Wang; N Mugo; A Mujugira; J M Baeten; J I Mullins; J P Hughes; E A Bukusi; C R Cohen; E Katabira; A Ronald; J Kiarie; C Farquhar; G J Stewart; J Makhema; M Essex; E Were; K H Fife; G de Bruyn; G E Gray; J A McIntyre; R Manongi; S Kapiga; D Coetzee; S Allen; M Inambao; K Kayitenkore; E Karita; W Kanweka; S Delany; H Rees; B Vwalika; W Stevens; M S Campbell; K K Thomas; R W Coombs; R Morrow; W L H Whittington; M J McElrath; L Barnes; R Ridzon; L Corey
Journal:  N Engl J Med       Date:  2010-01-20       Impact factor: 91.245

4.  A missed point in deciphering the viral synergy between herpes simplex virus and HIV.

Authors:  Andrea Lisco; Christophe Vanpouille; Leonid Margolis
Journal:  Lancet Infect Dis       Date:  2009-09       Impact factor: 25.071

5.  Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.

Authors:  Connie Celum; Anna Wald; James Hughes; Jorge Sanchez; Stewart Reid; Sinead Delany-Moretlwe; Frances Cowan; Martin Casapia; Abner Ortiz; Jonathan Fuchs; Susan Buchbinder; Beryl Koblin; Sheryl Zwerski; Scott Rose; Jing Wang; Lawrence Corey
Journal:  Lancet       Date:  2008-06-21       Impact factor: 79.321

6.  Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.

Authors:  Sinéad Delany; Nonkululeko Mlaba; Tim Clayton; Godspower Akpomiemie; Alexio Capovilla; Jerome Legoff; Laurent Belec; Wendy Stevens; Helen Rees; Philippe Mayaud
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

7.  Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.

Authors:  Nicolas Nagot; Abdoulaye Ouédraogo; Vincent Foulongne; Issouf Konaté; Helen A Weiss; Laurence Vergne; Marie-Christine Defer; Didier Djagbaré; Anselme Sanon; Jean-Baptiste Andonaba; Pierre Becquart; Michel Segondy; Roselyne Vallo; Adrien Sawadogo; Philippe Van de Perre; Philippe Mayaud
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

8.  Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics.

Authors:  Esther E Freeman; Kate K Orroth; Richard G White; Judith R Glynn; Roel Bakker; Marie-Claude Boily; Dik Habbema; Anne Buvé; Richard Hayes
Journal:  Sex Transm Infect       Date:  2007-04-03       Impact factor: 3.519

Review 9.  Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

Authors:  Esther E Freeman; Helen A Weiss; Judith R Glynn; Pamela L Cross; James A Whitworth; Richard J Hayes
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

10.  Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.

Authors:  Clare Tanton; Helen A Weiss; Mary Rusizoka; Jerome Legoff; John Changalucha; Kathy Baisley; Kokugonza Mugeye; Dean Everett; Laurent Belec; Tim C Clayton; David A Ross; Richard J Hayes; Deborah Watson-Jones
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

View more
  5 in total

Review 1.  Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions.

Authors:  Ruanne V Barnabas; Connie Celum
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

2.  Comparative performance of the Uni-Gold™ HSV-2 Rapid: a point-of-care HSV-2 diagnostic test in unselected sera from a reference laboratory.

Authors:  Enda Shevlin; Rhoda Ashley Morrow
Journal:  J Clin Virol       Date:  2014-08-27       Impact factor: 3.168

3.  Global population-level association between herpes simplex virus 2 prevalence and HIV prevalence.

Authors:  Silva P Kouyoumjian; Marieke Heijnen; Karima Chaabna; Ghina R Mumtaz; Ryosuke Omori; Peter Vickerman; Laith J Abu-Raddad
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

4.  HIV and herpes simplex virus type 2 epidemiological synergy: misguided observational evidence? A modelling study.

Authors:  Ryosuke Omori; Nico Nagelkerke; Laith J Abu-Raddad
Journal:  Sex Transm Infect       Date:  2017-12-04       Impact factor: 3.519

5.  Sexual network drivers of HIV and herpes simplex virus type 2 transmission.

Authors:  Ryosuke Omori; Laith J Abu-Raddad
Journal:  AIDS       Date:  2017-07-31       Impact factor: 4.177

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.